Intra-uterine exposure to maternal opiate abuse and HIV: The impact on the developing nervous system

Early Human Development

Volumn 89, Issue 4, 2013, Pages 229-235

  Palchik, Alexander B ^a   Einspieler, Christa ^b   Evstafeyeva, Irina V ^a,c   Talisa, Victor B ^d   Marschik, Peter B ^b,d  

^a SAINT PETERSBURG STATE PEDIATRIC MEDICAL UNIVERSITY   (Russian Federation)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

^c not available   (Russian Federation)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Fidgety movements; General movements; HIV exposure; HIV infection; Infant; Maternal opiate abuse; Neurodevelopmental outcome; Social deprivation

Indexed keywords

OPIATE;

ARTICLE; CHILD; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MOVEMENT (PHYSIOLOGY); NERVE CELL DIFFERENTIATION; NERVOUS SYSTEM DEVELOPMENT; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; VIDEORECORDING; WRITHING TEST;

EID: 84875369457     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2013.02.004     Document Type: Article

References (51)

1. Early child development - a winning combination. Lancet 2011, 378:1276. No authors listed.
2. Baillieu N., Potterton J. The extent of delay in language, motor and cognitive development in HIV-positive infants. J Neurol Phys Ther 2008, 32:118-121.
3. The European Collaborative Study Therapeutic and other interventions to reduce the risk of mother-to-child transmission of HIV-1 in Europe. Br J Obstet Gynaecol 1998, 105:704-709.
4. Mitchell W. Neurological and developmental effects of HIV and AIDS in children and adolescents. Ment Retard Dev Disabil Res Rev 2001, 7:211-216.
5. Koyanagi A., Humphrey J.H., Ntozini R., Nathoo K., Moulton L.H., Iliff P., et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011, 30:45-51.
6. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Stratdee S.A., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372:1733-1745.
7. http://ecdc.europa.eu/en/publications/publications/20121130-annual-hiv-surveillance-report.pdf.
8. Patil S., Bhosale R., Sambarey P., Gupte N., Suryavanshi N., Sastry J., et al. Impact of maternal human immunodeficiency virus infection on pregnancy and birth outcomes in Pune, India. AIDS Care 2011, 23:1562-1569.
9. Hernàndez S., Morén C., López M., Coll O., Cardellach F., Gratacós E., et al. Perinatal outcomes, mitochondrial toxicity and apoptosis in HIV-treated pregnant women and in-utero-exposed newborn. AIDS 2012, 26:419-428.
10. Joseph O., Biodun O., Michael E. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection. J Coll Physicians Surg Pak 2011, 21:356-359.
11. Neu N., Leighty R., Adeniyi-Jones S., Diaz C., Handelsman E., Kaufman G., et al. Women and Infants Transmission Study. Immune parameters and morbidity in hard drug and human immunodeficiency virus-exposed but uninfected infants. Pediatrics 2004, 113:1260-1266.
12. Ornoy A. The impact of intra-uterine exposure versus postnatal environment in neurodevelopmental toxicity: long-term neurobehavioural studies in children at risk for developmental disorders. Toxicol Lett 2003, 140-141:171-181.
13. Bandstra E.S., Morrow C.E., Mansoor E., Accornero V.H. Prenatal drug exposure: infant and toddler outcomes. J Addict Dis 2010, 29:245-258.
14. McGlone L., Mactier H., Weaver L.T. Drug misuse in pregnancy: losing sight of the baby?. Arch Dis Child 2009, 94:708-712.
15. Van Baar A., de Graaf B.M.T. Cognitive development at preschool-age of infants of drug-dependent mothers. Dev Med Child Neurol 1994, 157:724-730.
16. Topley J., Windsor D., Williams R. Behavioural, development and child protection outcomes following exposure to class A drug in pregnancy. Child Care Health Dev 2007, 34:71-76.
17. Bell J., Harvey-Dodds L. Pregnancy and injecting drug use. Br Med J 2008, 336:1303-1305.
18. Prechtl H.F., Einspieler C., Cioni G., Bos A.F., Ferrari F., Sontheimer D. An early marker for neurological deficits after perinatal brain lesions. Lancet 1997, 349:1361-1363.
19. Einspieler C., Prechtl H.F. Prechtl's assessment of general movements: a diagnostic tool for the functional assessment of the young nervous system. Ment Retard Dev Disabil Res Rev 2005, 11:61-67.
20. Noble Y., Boyd R. Neonatal assessment for the preterm infant up to 4months corrected age: a systematic review. Dev Med Child Neurol 2012, 54:129-139.
21. Einspieler C., Prechtl H.F., Bos A.F., Ferrari F., Cioni G. Prechtl's method on the quantitative assessment of general movements in preterm, term and young infants 2004, Mac Keith Press (distributed by Cambridge University Press), London.
22. Griffiths R. The abilities of young children 1970, Child Development Research Center, London.
23. Zhurba L.T., Mastyukova E.A. Neurodevelopmental disturbances in infants 1981, Medicine, Moscow, [in Russian].
24. Amiel-Tison C., Ellison P. Birth asphyxia in the full term newborn: early assessment and outcome. Dev Med Child Neurol 1986, 28:671-681.
25. De Vries N.K., Bos A.F. The quality of general movements in the first ten days of life in preterm infants. Early Hum Dev 2010, 86:225-229.
26. Nakajima Y., Einspieler C., Marschik P.B., Bos A.F., Prechtl H.F. Does a detailed assessment of poor repertoire general movements help to identify those infants who will develop normally?. Early Hum Dev 2006, 82:53-59.
27. Beccaria E., Martino M., Briatore E., Podesta B., Pomero G., Micciolo R., et al. Poor repertoire general movements predict some aspects of development outcome at 2years in very preterm infants. Early Hum Dev 2012, 88:393-396.
28. Ferrari F., Cioni G., Einspieler C., Roversi M.F., Bos A.F., Paolicelli P.B., et al. Cramped synchronized general movements in preterm infants as an early marker for cerebral palsy. Arch Pediatr Adolesc Med 2002, 156:460-467.
29. Bruggink J.L., Einspieler C., Butcher P., van Braekel K., Prechtl H.F., Bos A.F. The quality of the early motor repertoire in preterm infants predicts minor neurologic dysfunction at school age. J Pediatr 2008, 153:32-39.
30. Einspieler C., Marschik P.B., Milioti S., Nakajima Y., Bos A.F., Prechtl H.F. Are abnormal fidgety movements an early marker for complex minor neurological dysfunction at puberty?. Early Hum Dev 2007, 83:521-525.
31. Elstner T., Fiala-Preinsperger S., Einspieler C., Prechtl H., Berger E. Early spontaneous movements in infants of substance abusing mothers. Brain Dev 2001, 23:A24.
32. Yuge M., Marschik P.B., Nakajima Y., Yamori Y., Kanda T., Hirota H., et al. Movements and postures of infants aged 3 to 5months: to what extent is their optimality related to perinatal events and to the neurological outcome. Early Hum Dev 2011, 87:231-237.
33. Phagava H., Muratori F., Einspieler C., Maestro S., Apicella F., Guzzetta A., et al. General movements in infants with autism spectrum disorders. Georgian Med News 2008, 156:100-105.
34. Einspieler C., Cioni G., Paolicelli P.B., Bos A.F., Dressler A., Ferrari F., et al. The early markers for later dyskinetic cerebral palsy are different from those for spastic cerebral palsy. Neuropediatrics 2002, 33:73-78.
35. Prechtl H.F.R. General movement assessment as a method of developmental neurology: new paradigms and their consequences. The 1999 Ronnie MacKeith Lecture. Dev Med Child Neurol 2001, 43:836-842.
36. Cooper S., Lyall H., Walters S., Tudor-Williams G., Habibi P., de Munter C., et al. Children with human immunodeficiency virus admitted to a paediatric intensive care unit in the United Kingdom over a 10-year period. Intensive Care Med 2004, 30:113-118.
37. Nozyce M.L., Lee S.S., Wiznia A., Nachman S., Mofenson L.M., Smith M.E., et al. A behavioural and cognitive profile of clinically stable HIV infected children. Pediatrics 2006, 117:763-770.
38. Hultman C.M., Torrang A., Tuvblad C., Cnattingius S., Larsson J.O., Lichtenstein P. Birth weight and attention-deficit/hyperactivity symptoms in childhood and early adolescence: a prospective Swedish twin study. J Am Acad Child Adolesc Psychiatry 2007, 46:370-377.
39. Rutter M., Andersen-Wood L., Beckett C., Bredenkamp D., Castle J., Groothuis C., et al. Quasi-autistic patterns following severe early global privation. English and Romanian Adoptees (ERA) Study Team. Child Psychol Psychiatry 1999, 40:537-549.
40. Landgren M., Svensson L., Strömland K., Andersson Grönlund M. Prenatal alcohol exposure and neurodevelopmental disorders in children adopted from Eastern Europe. Pediatrics 2010, 125:1178-1185.
41. Thompson L., Kemp J., Wilson P., Pritchett R., Minnis H., Toms-Whittle L., et al. What have birth cohort studies asked about genetic, pre- and perinatal exposures and child and adolescent onset mental health outcomes? A systematic review. Eur Child Adolesc Psychiatry 2010, 19:1-15.
42. Einspieler C., Widder J., Holzer A., Kenner T. The predictive value of behavioural risk factors for sudden infant death. Early Hum Dev 1988, 18:101-109.
43. Einspieler C., Kerr A.M., Prechtl H.F. Abnormal general movements in girls with Rett disorder: the first four months of life. Brain Dev 2005, 27:S8-S13.
44. Hadders-Algra M., Bouwstra H., Groen S.E. Quality of general movements and psychiatric morbidity at 9 to 12years. Early Hum Dev 2009, 85:1-6.
45. Salihu H.M., August E.M., Aliyu M., Stanley K.M., Weldeselasse H., Mbah A.K. Maternal HIV/AIDS status and neurological outcomes in neonates: a population-based study. Matern Child Health J 2012, 16:641-648.
46. Blasini I., Velez-Borras J., Hittelman J., Ware J., Smith R., Chase C. Early neurodevelopmental indicators of encephalopathy in vertically HIV-infected children. Neuroscience of HIV infection. J Neurovirol 1998, 4:343.
47. Gay C.L., Armstrong F.D., Cohen D., Lai S., Hardy M.D., Swales T.P., et al. The effects of HIV on cognitive and motor development in children born to HIV-seropositive women with no report drug use: birth to 24months. Pediatrics 1995, 96:1078-1082.
48. Nozyce M., Hittelman J., Muenz L., Durako S.J., Fischer M.L., Willoughby A. Effect of perinatally acquired immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics 1994, 94:883-891.
49. Fishkin P.E., Armstrong F.D., Routh D.K., Harris L., Thompson W., Miloslavich K., et al. Brief report: relationship between HIV infection and WPPSI-R performance in preschool-age children. J Pediatr Psychol 2000, 25:347-351.
50. Chugani H.T., Behen M.E., Muzik O., Juhász C., Nagy F., Chugani D.C. Local brain functional activity following early deprivation: a study of postinstitutionalized Romanian orphans. Neuroimage 2001, 14:1290-1301.
51. Eluvathingal T.J., Chugani H.T., Behen M.E., Juhász C., Muzik O., Maqbool M., et al. Abnormal brain connectivity in children after early severe socioemotional deprivation: a diffusion tensor imaging study. Pediatrics 2006, 117:2093-2100.